Literature DB >> 16805926

Performance on MMSE sub-items and education level in presenilin-1 mutation carriers without dementia.

John M Ringman1, Yaneth Rodriguez, Claudia Diaz-Olavarrieta, Mireya Chavez, Michael Thompson, Lynn Fairbanks, Francisco Paz, Arousiak Varpetian, Hector Chaparro, Miguel Angel Macias-Islas, Jill Murrell, Bernardino Ghetti, Claudia Kawas.   

Abstract

BACKGROUND: Spanish-language screening tests that are sensitive to the early cognitive changes of Alzheimer's disease (AD) are needed. Persons known to be at 50% risk for young-onset AD due to presenilin-1 (PSEN1) mutations provide the opportunity to assess which measures on the Mini-mental State Examination (MMSE) are most sensitive to these early changes.
METHODS: We performed genetic and Spanish-language cognitive testing on 50 Mexican persons without dementia at risk for inheriting PSEN1 mutations. We then compared the performance on sub-items of the MMSE between PSEN1 mutation carriers (MCs) and non-carriers (NCs) using t-tests and Fisher's exact tests. Exploratory multiple logistic regression analyses were also performed.
RESULTS: Twenty-nine persons were MCs and 21 NCs. NCs tended to achieve higher levels of education (p = 0.039) than did MCs. MCs tended to perform more poorly when spelling "MUNDO" backwards and on Orientation, particularly regarding the date. In multiple regression analyses the ability of backwards spelling to predict PSEN1 mutation status was reduced when education was included as an independent variable.
CONCLUSION: Subjects in the earliest stage of PSEN1-related AD showed deficits on orientation to date and in divided attention when spelling backwards. It is unclear if educational level should be considered an associated feature or a con-founding variable in this population although it should be taken into account when considering performance on the MMSE task of divided attention. The relative lack of deficits on delayed recall of three words probably represents the insensitivity of this measure in early AD. This study supports the utility of autosomal dominant AD as a model of the more common sporadic form of the disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16805926      PMCID: PMC3373254          DOI: 10.1017/S1041610206003772

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  18 in total

1.  Sensitivity and specificity of the Mini-Mental State Examination in a Spanish-speaking population.

Authors:  F Ostrosky-Solís; G López-Arango; A Ardila
Journal:  Appl Neuropsychol       Date:  2000

2.  Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation.

Authors:  G Raux; R Gantier; C Thomas-Anterion; J Boulliat; P Verpillat; D Hannequin; A Brice; T Frebourg; D Campion
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

Review 3.  Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration.

Authors:  Dennis Selkoe; Raphael Kopan
Journal:  Annu Rev Neurosci       Date:  2003-04-18       Impact factor: 12.449

4.  Neuropsychological function in nondemented carriers of presenilin-1 mutations.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; L Fairbanks; F Paz; A Varpetian; H C Maldonado; M A Macias-Islas; J Murrell; B Ghetti; C Kawas
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

Review 5.  New frontiers in Alzheimer's disease genetics.

Authors:  R E Tanzi; L Bertram
Journal:  Neuron       Date:  2001-10-25       Impact factor: 17.173

6.  Development of psychometrically matched English and Spanish language neuropsychological tests for older persons.

Authors:  D Mungas; B R Reed; S C Marshall; H M González
Journal:  Neuropsychology       Date:  2000-04       Impact factor: 3.295

7.  Familial Alzheimer's disease: site of mutation influences clinical phenotype.

Authors:  C F Lippa; J M Swearer; K J Kane; D Nochlin; T D Bird; B Ghetti; L E Nee; P St George-Hyslop; D A Pollen; D A Drachman
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

8.  Mini-Mental State Examination and Mattis Dementia Rating Scale performance differs in Hispanic and non-Hispanic Alzheimer's disease patients.

Authors:  U Hohl; M Grundman; D P Salmon; R G Thomas; L J Thal
Journal:  J Int Neuropsychol Soc       Date:  1999-05       Impact factor: 2.892

9.  Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging.

Authors:  John Meyer; Gelin Xu; John Thornby; Munir Chowdhury; Minh Quach
Journal:  J Neurol Sci       Date:  2002-09-15       Impact factor: 3.181

10.  Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.

Authors:  Armando Estévez-González; Jaime Kulisevsky; Anunciación Boltes; Pilar Otermín; Carmen García-Sánchez
Journal:  Int J Geriatr Psychiatry       Date:  2003-11       Impact factor: 3.485

View more
  5 in total

1.  Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.

Authors:  Luis D Medina; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Paul E Gilbert; Li-Jung Liang; Jeffrey L Cummings; John M Ringman
Journal:  Dement Geriatr Cogn Disord       Date:  2011-08-30       Impact factor: 2.959

2.  Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.

Authors:  Lauren M Wright; Thor D Stein; Gyungah Jun; Jaeyoon Chung; Kate McConnell; Marissa Fiorello; Nicole Siegel; Steven Ness; Weiming Xia; Kelley L Turner; Manju L Subramanian
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson's Disease.

Authors:  Wenhua Sun; Jinhua Zheng; Jianjun Ma; Zhidong Wang; Xiaoxue Shi; Mingjian Li; Shen Huang; Shiyu Hu; Zhenxiang Zhao; Dongsheng Li
Journal:  Front Aging Neurosci       Date:  2021-02-12       Impact factor: 5.750

4.  Plasma arylsulfatase A levels are associated with cognitive function in Parkinson's disease.

Authors:  Mingjian Li; Xiaoxue Shi; Jianjun Ma; Wenhua Sun; Zhidong Wang; Dongsheng Li; Jinhua Zheng; Zhenxiang Zhao; Qi Gu; Siyuan Chen
Journal:  Neurol Sci       Date:  2022-04-29       Impact factor: 3.830

5.  PSEN1 c.1292C<A Variant and Early-Onset Alzheimer's Disease: A Scoping Review.

Authors:  Maribel Orozco-Barajas; Yulisa Oropeza-Ruvalcaba; Alejandro A Canales-Aguirre; Victor J Sánchez-González
Journal:  Front Aging Neurosci       Date:  2022-07-22       Impact factor: 5.702

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.